Metastatic Colorectal Cancer (CRC)
Oncology
2
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
TakedaFruquintinib Combined With Chemotherapy
Boehringer IngelheimBI 1701963
Clinical Trials (2)
Total enrollment: 65 patients across 2 trials
Trial of 5-Fluorouracil (5FU)-Based Therapy in Combination With Fruquintinib in Patients With Locally Advanced Unresectable or Metastatic Colorectal Cancer
Start: Feb 2026Est. completion: Dec 202950 patients
Phase 2Recruiting
A Study to Test Different Doses of BI 1701963 in Combination With Irinotecan in People With Advanced Bowel Cancer With Kirsten Rat Sarcoma Viral Oncogene Homologue (KRAS) Mutation
Start: Nov 2020Est. completion: Jan 202215 patients
Phase 1Terminated
Related Jobs in Oncology
Operator
Sartorius Stedim Biotech
Shanghai
10h ago
Operator
Sartorius Stedim Biotech
Shanghai
10h ago
Clinical Trials Manager
Tango Therapeutics
Boston, MA
10h ago
Summer intern Neuroscience
Arvinas
New Haven - CT
Yesterday
Scientist (R3)
Pfizer
Ireland - Dublin - Grange Castle
Yesterday
Physician Director Oncology Data Science - Translational Science
GSK
USA - Pennsylvania - Upper Providence
Yesterday
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 65 patients
2 companies competing in this space